These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6104903)

  • 1. Possible role of opiate receptors and des-tyrosine1-gamma-endorphin in schizophrenia.
    Pedigo NW; Reisine TD; Schallert T; Overstreet DH; Ling NC; Ragan P; Yamamura HI
    Adv Biochem Psychopharmacol; 1980; 22():549-62. PubMed ID: 6104903
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of effect of des-tyrosine1-gamma-endorphin on in vivo [3H]spiperone binding.
    Lahti RA; Gay DD
    Eur J Pharmacol; 1982 May; 80(1):127-9. PubMed ID: 6124435
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of in vivo 3H-spiperone binding by the proposed antipsychotic Des-Tyr1-gamma-endorphin.
    Pedigo NW; Schallert T; Overstreet DH; Ling NC; Ragan P; Reisine TD; Yamamura HI
    Eur J Pharmacol; 1979 Dec; 60(4):359-64. PubMed ID: 43261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endorphins in schizophrenia.
    van Ree JM; De Wied D
    Neuropharmacology; 1981 Dec; 20(12B):1271-7. PubMed ID: 6172743
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endorphins and their significance for psychopathology].
    van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1979 Mar; 123(9):327-34. PubMed ID: 216935
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endomorphines in schizophrenia].
    Gilbert JL
    Biomed Pharmacother; 1987; 41(1):36-40. PubMed ID: 3038207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-like and antipsychotic effects of gamma-type endorphins.
    Van Ree JM; Verhoeven WM; Van Praag HM; De Wied D
    Mod Probl Pharmacopsychiatry; 1981; 17():266-78. PubMed ID: 6173744
    [No Abstract]   [Full Text] [Related]  

  • 8. [The endorphin hypothesis of schizophrenia].
    Słowik S
    Psychiatr Pol; 1982; 16(1-2):91-9. PubMed ID: 6292978
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigating the role of endogenous opioid peptides in psychiatric disorders.
    Berger PA
    Neurosci Res Program Bull; 1978 Dec; 16(4):585-99. PubMed ID: 35766
    [No Abstract]   [Full Text] [Related]  

  • 10. The interaction between gamma-type endorphins and HLA class I antigens.
    Claas FH; van Ree JM; Verhoeven WM; van der Poel JJ; Verduyn W; de Wied D; van Rood JJ
    Hum Immunol; 1986 Apr; 15(4):347-56. PubMed ID: 2422143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Endorphin: radioreceptor binding assay. Relative potency of synthetic analogs with various chain lengths.
    Ferrara P; Li CH
    Int J Pept Protein Res; 1980 Jul; 16(1):66-9. PubMed ID: 6254895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M; Laforge E; Muyard J; Blayac J; Lemoine J
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding sites for non-opioid gamma-type endorphins in brain structures of the mesocorticolimbic feedback circuit.
    Wiegant VM; Ronken E; de Boer T; Tonnaer JA
    Prog Clin Biol Res; 1990; 328():29-32. PubMed ID: 1689494
    [No Abstract]   [Full Text] [Related]  

  • 14. 3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment.
    Leysen JE
    Adv Biochem Psychopharmacol; 1980; 24():123-32. PubMed ID: 6105770
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-Endorphin, gamma-endorphin, and their des-tyrosine fragments: distribution in rat brain.
    Verhoef J; Wiegant VM; De Wied D
    Adv Biochem Psychopharmacol; 1982; 33():69-74. PubMed ID: 6181665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endogenous opiate peptides].
    Płaźnik A; Puciłowski O; Kostowski W
    Pol Tyg Lek; 1982 Oct; 37(38):1149-53. PubMed ID: 6298757
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
    Höllt V
    Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Des-1-tyrosine-gamma-endorphin: an assessment of its neuroleptic properties and effect on dopamine synthesis].
    Raevskiĭ KS; Shemanov AIu; Kudrin VS
    Farmakol Toksikol; 1982; 45(5):5-8. PubMed ID: 6128254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of des-tyrosine1-gamma-endorphin activity at oH-spiroperidol binding sites in rat brain.
    Pedigo NW; Ling NC; Reisine TD; Yamamura HI
    Life Sci; 1979 Apr; 24(18):1645-9. PubMed ID: 481099
    [No Abstract]   [Full Text] [Related]  

  • 20. Opiate receptors and their implications for drug addiction.
    Simon EJ
    NIDA Res Monogr; 1980 Mar; 30():303-8. PubMed ID: 6256635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.